Sanofi (SANOFI80)
Thailand Exchange · Thailand · prices in THB · close of 20 Oct 2026
Key indicators
| Last close | THB 2.720 |
|---|---|
| 52-week range | 2.638 – 3.265 |
| Return, 1 month / 3 months | −4.9% / −8.1% |
| Return, 1 year / 3 years | −9.9% / – |
| Trend | Below its 200-day average |
| RSI (14) | 43 |
| Volatility (1 year) | 23.0% |
| Worst drawdown (1 year) | -16.6% |
| Average daily value traded | 0.26M THB |
| Dividend yield | 5.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sanofi is a pharmaceutical company based in France that researches, develops and makes medicines and vaccines. It supplies prescription drugs for conditions such as diabetes, rare diseases and cardiovascular illness, along with vaccines and consumer health products sold in pharmacies. Its customers are mainly hospitals, doctors, pharmacists and health systems in many countries around the world. The company also produces over-the-counter remedies for everyday ailments through its consumer healthcare business.
The shares are listed on the Thailand Exchange in Thailand under the code SANOFI80, and the price on this page is in Thai baht (THB). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sanofi (SANOFI80) trades on the Thailand Exchange in Thailand. It last closed at THB 2.720 on 20 October 2026.
Its price-based Market X-Ray is 44 out of 100 (a weak price profile), ranking 806 of 1,348 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 9.9% and over the last three months it fell 8.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Thailand Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 37 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -4.5% | ||
| From 52-week high | -15.2% | ||
| Momentum | 30 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -8.1% | ||
| 6-month return | -9.9% | ||
| 12-month return, skipping the last month | -5.2% | ||
| Stability (higher is calmer) | 79 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 23.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.6% | ||
| Liquidity | 26 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.26M THB | ||
| Zero-volume days | 5.0% | ||
| Income | 40 · Weak | Dividend is small or irregular. | |
| Dividend yield | 5.6% | ||
| Years with dividends | 2 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | −4.9% |
| 3 months | −8.1% |
| 6 months | −9.9% |
| 1 year | −9.9% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 2.851 / 2.849 |
|---|---|
| Golden / death cross (60 days) | Golden, 40 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.055 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 May 2026 | EUR 0.1528 |
| 13 May 2025 | EUR 4.7704 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Thailand Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.